JCR Pharmaceuticals Co. Ltd. | Cash Flow
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,677
2,334
2,459
2,493
3,895
4,928
Depreciation, Depletion & Amortization
1,112
1,352
1,408
1,448
1,382
1,343
Other Funds
546
886
275
1,149
41
1,147
Funds from Operations
2,244
2,800
3,592
2,792
5,236
5,126
Changes in Working Capital
2,322
2,301
1,391
140
2,103
1,221
Net Operating Cash Flow
4,565
499
2,202
2,651
3,133
3,905
Capital Expenditures
2,410
1,340
1,414
1,551
999
Sale of Fixed Assets & Businesses
65
-
-
-
250
Purchase/Sale of Investments
322
83
459
694
655
Net Investing Cash Flow
2,668
1,420
981
841
1,403
Cash Dividends Paid - Total
413
592
640
699
748
Issuance/Reduction of Debt, Net
15
709
469
1,589
975
Net Financing Cash Flow
369
1,261
1,314
146
2,359
Net Change in Cash
1,632
2,138
120
1,941
615
Free Cash Flow
2,156
779
788
1,101
2,211
Change in Capital Stock
28
40
205
744
2,585
Exchange Rate Effect
104
44
27
15
14
About JCR Pharmaceuticals Co.
View Profile
